Characteristics and Clinical Outcomes of COVID-19 in ESRD Patients Undergoing Hemodialysis in Ngudi Waluyo Wlingi General Hospital in 2020-2022
Abstract
Background: The coronavirus disease (COVID-19) pandemic is a major threat to global health care. Comorbidities, including end-stage renal disease (ESRD), are related to an increased risk of severe infection and mortality.
Objective: To assess determinants related to the clinical outcomes of COVID-19 in ESRD patients undergoing hemodialysis in Ngudi Waluyo Wlingi General Hospital in 2020-2022.
Methods: This study included ESRD patients undergoing maintenance hemodialysis who were hospitalized at Ngudi Waluyo Wlingi General Hospital due to COVID-19 from May 2020 to February 2022. Clinical characteristics were investigated in relation to the severity and survival status.
Results: A total of 26 patients (46.15% male) with a mean age of 52.27±13.65 years met the inclusion criteria. Of these, 42.3% had a mild infection, 23% had a moderate infection, 30.77% had a severe infection, and 3.8% had a critical infection. The mortality rate was 23.08%, with a mean length of stay of 15.19±7 days. Age, oxygen saturation, respiratory rate upon admission, lymphocyte and neutrophil levels, and neutrophil-to-lymphocyte ratio were significantly associated with COVID-19 severity. Length of stay was statistically influenced by respiratory rate upon admission. The mortality rate was correlated with the dialysis vintage, levels of hemoglobin, leukocytes, platelets, neutrophils, neutrophil-to-lymphocyte ratio, serum urea, serum creatinine, eGFR, and length of stay.
Conclusion: COVID-19 in ESRD patients undergoing hemodialysis were more likely to have a poor prognosis. Identifying determinants is crucial for reducing morbidity and mortality.
Downloads
References
WHO. Number of COVID-19 cases reported to WHO (cumulative total) [Internet]. World Health Organization. 2024. Available from: https://data.who.int/dashboards/covid19/cases?n=o
Jdiaa SS, Mansour R, El Alayli A, Gautam A, Thomas P, Mustafa RA. COVID–19 and chronic kidney disease: an updated overview of reviews. J Nephrol. 2022;35(1):69–85. doi:10.1007/s40620-021-01206-8
Hyodo T, Hirawa N, Kuragano T, Takemoto Y, Pham B V, Nguyen HM. The status of dialysis patients in Asian countries under COVID-19 disaster as of December 2019–June 2022: Vietnam, Indonesia, and Mongolia. Ren Replace Ther. 2024;10(1):1–12. doi:10.1186/s41100-024-00572-w
Perhimpunan Dokter Paru Indonesia (PDPI), Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI), Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia (PAPDI), Perhimpunan Dokter Anestesiologi dan Terapi Intensif Indonesia (PERDATIN), Ikatan Dokter Anak Indonesia (IDAI). Pedoman tatalaksana COVID-19. 4th ed. Jakarta; 2022.
Li P, Guan Y, Zhou S, Wang E, Sun P, Fei G, et al. Mortality and risk factors for COVID-19 in hemodialysis patients: A systematic review and meta-analysis. Sci Prog. 2022;105(3):003685042211108. doi:10.1177/00368504221110858
Ahmed N, Khderat AH, Sarsour A, Taher A, Hammoudi A, Hamdan Z, et al. The vulnerability of maintenance dialysis patients with COVID-19: mortality and risk factors from a developing country. Ann Med. 2022;54(1):1511–9. doi:10.1080/07853890.2022.2075914
Brogan M, Ross MJ. COVID-19 and Kidney Disease. Annu Rev Med. 2023;74(1):1–13. doi:10.1146/annurev-med-042420-104753
Zhang X, Chen Q, Xu G. Clinical manifestations of COVID-19 infection in dialysis patients and protective effect of COVID-19 vaccine. Inflamm Res. 2023;72(5):989–1000. doi:10.1007/s00011-023-01723-1
Bhinder OS, Swarnim S, Mantan M, Dabas A, Ahlawat RS. Chronic Kidney Disease and COVID-19: Outcomes of hospitalised adults from a tertiary care centre in North India. Med J Armed Forces India. 2023;79(Suppl 1):S68–74. doi:10.1016/j.mjafi.2021.12.004
Zhu L, Li XL, Shi R, Wang DG. Dialysis vintage is associated with a high prevalence and severity of unpleasant symptoms in patients on hemodialysis. Ren Fail. 2023;45(1):2201361. doi:10.1080/0886022x.2023.2201361
González-Cuadrado C, Caro-Espada PJ, Chivite-Lacaba M, Utrero-Rico A, Lozano-Yuste C, Gutierrez-Solis E, et al. Hemodialysis-associated immune dysregulation in SARS-CoV-2-infected end-stage renal disease patients. Int J Mol Sci. 2023;24(2):1712. doi:10.3390/ijms24021712
Liu YF, Zhang Z, Pan XL, Xing GL, Zhang Y, Liu ZS, et al. The chronic kidney disease and acute kidney injury involvement in COVID-19 pandemic: A systematic review and meta-analysis. PLoS One. 2021;16(1):e0244779. doi:10.1371/journal.pone.0244779
Pranandhira RAW, Rahman EY, Khatimah H. Karakteristik pasien chronic kidney disease yang dilakukan hemodialisis di RSUD Ulin Banjarmasin selama pandemi COVID-19. Homeostasis. 2023;6(1):69–78. doi:10.20527/ht.v6i1.8790
Ghonimi TAL, Alkad MM, Abuhelaiqa EA, Othman MM, Elgaali MA, Ibrahim RAM, et al. Mortality and associated risk factors of COVID-19 infection in dialysis patients in Qatar: A nationwide cohort study. PLoS One. 2021;16(7):e0254246. doi:10.1371/journal.pone.0254246
Wang F, Ao G, Wang Y, Liu F, Bao M, Gao M, et al. Risk factors for mortality in hemodialysis patients with COVID-19: a systematic review and meta-analysis. Ren Fail. 2021;43(1):1394–407. doi:10.1080/0886022x.2021.1986408
Yilmaz G, Timur O. Factors related to mortality in hemodialysis patients with COVID-19. J Ren Inj Prev. 2023;12(4):e32005. doi:10.34172/jrip.2022.32005
Haq AD, Nugraha AP, Wibisana IKGA, Anggy F, Damayanti F, Syifa RRDM, et al. Faktor – faktor terkait tingkat keparahan infeksi coronavirus disease 2019 (COVID-19): sebuah kajian literatur. JIMKI. 2021;9(1):48–55. doi:10.53366/jimki.v9i1.338
SZE X, Fuah KW, Lim CTS, Alias AA, Fadhlina NZ, Md Shah A, et al. Pos-966 clinical outcome of Covid-19 infection and end stage kidney disease patients in a nephrology specialized ward: are we moving towards better? Kidney Int Rep. 2022;7(2):S421. doi:10.1016/j.ekir.2022.01.1006
Nasution MFG. Prevalence and characteristics of regular hemodialysis patients with COVID-19 at USU Hospital in 2020-2021 at the University Hospital of North Sumatra. Maj Kedokt Andalas. 2023;46(2):206–15. doi:10.25077/mka.v46.i2.p206-215.2023
Ziuzia-Januszewska L, Januszewski M, Sosnowska-Nowak J, Janiszewski M, Dobrzyński P, Jakimiuk AA, et al. COVID-19 severity and mortality in two pandemic waves in Poland and predictors of poor outcomes of SARS-CoV-2 infection in hospitalized young adults. Viruses. 2022;14(8):1700. doi:10.3390/v14081700
Gur E, Levy D, Topaz G, Naser R, Wand O, Kitay-Cohen Y, et al. Disease severity and renal outcomes of patients with chronic kidney disease infected with COVID-19. Clin Exp Nephrol. 2022;26(5):445–52. doi:10.1007/s10157-022-02180-6
Pecly IMD, Azevedo RB, Muxfeldt ES, Botelho BG, Albuquerque GG, Diniz PHP. COVID-19 and chronic kidney disease: a comprehensive review. J Bras Nefrol. 2021;43(3):383–99. doi:10.1590/2175-8239-jbn-2020-0203
Artborg A, Caldinelli A, Wijkström J, Nowak A, Fored M, Stendahl M, et al. Risk factors for COVID-19 hospitalization and mortality in patients with chronic kidney disease: a nationwide cohort study. Clin Kidney J. 2024;17(1):sfad283. doi:10.1093/ckj/sfad283
Al-Otaiby M, Almutairi KM, Vinluan JM, Al Seraihi A, Alonazi WB, Qahtani MH. Demographic characteristics, comorbidities, and length of stay of COVID-19 patients admitted into intensive care units in Saudi Arabia: A nationwide retrospective study. Front Med. 2022;9:893954. doi:10.3389/fmed.2022.893954
Arroyo E, Umukoro PE, Burney HN, Li Y, Li X, Lane KA. Initiation of dialysis is associated with impaired cardiovascular functional capacity. J Am Hear Assoc. 2022;11(14):e025656. doi:10.1161/jaha.122.025656
Karoui K El, Vriese AS De. COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment. Kidney Int. 2022;101(5):883–94. doi:10.1016/j.kint.2022.01.022
Cancarevic I, Nassar M, Daoud A, Ali H, Nso N, Sanchez A, et al. Mortality rate of COVID-19 infection in end stage kidney disease patients on maintenance hemodialysis: A systematic review and meta-analysis. World J Virol. 2022;11(5):352–61. doi:10.5501/wjv.v11.i5.352
Turgutalp K, Ozturk S, Arici M, Eren N, Gorgulu N, Islam M, et al. Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19. BMC Nephrol. 2021;22(1):29. doi:10.1186/s12882-021-02233-0
Ozturk S, Turgutalp K, Arici M, Odabas A, Altiparmak M, Aydin Z, et al. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey. Nephrol Dial Transpl. 2020;35(12):2083–95. doi:10.1093/ndt/gfaa271
Selvaskandan H, Hull KL, Adenwalla S, Ahmed S, Cusu MC, Graham-Brown M, et al. Risk factors associated with COVID-19 severity among patients on maintenance haemodialysis: a retrospective multicentre cross-sectional study in the UK. BMJ Open. 2022;12(5):e054869. doi:10.1136/bmjopen-2021-054869
Brogan M, Ross MJ. The impact of chronic kidney disease on outcomes of patients with COVID-19 admitted to the Intensive Care Unit. Nephron. 2022;146(1):67–71. doi:10.1159/000519530
Gunawan A, Rosita L, Arthamin MZ, Arifin MS, Apramadha N, Normahayu I. Does end stage renal disease increase severity of COVID-19? Udayana J Intern Med. 2023;7(1):7–10. doi:10.36216/jpd.v7i1.197
Kang SH, Kim SW, Kim AY, Cho KH, Park JW, Do JY. Association between chronic kidney disease or acute kidney injury and clinical outcomes in COVID-19 patients. J Korean Med Sci. 2020;35(50):e434. doi:10.3346/jkms.2020.35.e434
Supayah J, Wong HS, Lee FY, Chidambaram SK, Wong EFS. Pos-965 Characteristics, predictive factors and outcomes of hemodialysis patients with Covid 19 infection in the Intensive Care Unit at a State Covid Referral Centre. Kidney Int Rep. 2022;7(2):S421. doi:10.1016/j.ekir.2022.01.1005
Choi JY, Smith DM. SARS-CoV-2 variants of concern. Yonsei Med J. 2021;62(11):961–8. doi:10.3349/ymj.2021.62.11.961
Haryati H, Rahmawaty D, Isa M, Assagaf A, Nurrasyidah I, Kusumawardhani E. Clinical characteristic of different SARS-CoV-2 variants in South Kalimantan, Indonesia: A case study. Althea Med J [Internet]. 2023;10(1). Available from: https://journal.fk.unpad.ac.id/index.php/amj/article/view/2810doi:10.15850/amj.v10n1.2810
Copyright (c) 2024 Indonesian Journal of Kidney and Hypertension

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Indonesian Journal of Kidney and Hypertension agree to the following terms:
- Authors retain copyright and grant Indonesian Journal of Kidney and Hypertension right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Indonesian Journal of Kidney and Hypertension.
- Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Indonesian Journal of Kidney and Hypertension.